Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57K Sell
238
-219
-48% -$4.84K ﹤0.01% 1407
2026
Q1
$6.68K Buy
457
+451
+7,517% +$6.62K ﹤0.01% 1448
2025
Q4
$76 Sell
6
-260
-98% -$3.83K ﹤0.01% 2590
2025
Q3
$4.09K Buy
266
+135
+103% +$2.18K ﹤0.01% 1502
2025
Q2
$2.06K Buy
+131
New +$1.99K ﹤0.01% 1311

Other funds holding RXO

Essential Partners's RXO Position: Q2 2026 in Review

Essential Partners reduced its RXO (RXO) stake by 48% in Q2 2026, selling an estimated $4.84K and leaving 238 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Essential Partners first reported a position in RXO in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.68K in Q1 2026. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Essential Partners held 238 shares of RXO worth $6.57K as of Q2 2026.
  • Essential Partners sold 219 RXO shares in Q2 2026, an estimated $4.84K.
  • RXO made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1407 holding.
  • Essential Partners first reported a position in RXO in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's RXO position peaked at $6.68K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.